Microsoft word - wspa-wa rx cns muscle relaxants pearls.doc
CNS Muscle Relaxants
Clinical Pearls for the Washington Rx Therapeutic Interchange Program (TIP)
Steve Riddle, BS Pharm, BCPS
In 2003, the Washington State Pharmacy and Therapeutics Committee (P&T), the agency directors of the Department of
Social and Health Services-Medical Assistance Administration (DSHS-MAA), Labor and Industries (L&I), and the Health
Care Authority-Uniform Medical Plan (UMP) declared baclofen, chlorzoxaxone, cyclobenzaprine and methocarbamol to be
the “preferred” CNS muscle relaxants for patients covered by their prescription insurance. Patients currently using “non-
preferred” agents” must be evaluated for conversion to a preferred agent. Furthermore, patients presenting
with prescriptions for non-preferred agents from “endorsing practitioners” (i.e., providers that have signed the TIP
agreement) may be automatically converted to preferred agents by pharmacists once this program is operational. Purpose
The purpose of this document is to inform pharmacists of the clinical, safety and cost rationale for these policy changes and
to optimize their ability to assure safe and effective conversion of patients to the appropriate agents.
Washington State Evidence Based Preferred Drug List Preferred CNS Muscle Relaxants are:
Skeletal muscle relaxants are a mixed group of medications that are used to treat two different types of conditions:
1) Musculo-skeletal conditions causing tenderness and muscle spasms include fibromyalgia, tension headaches, neck
2) Spasticity, a clinical condition characterized by increased muscle tone from such neurological conditions as
Currently Available Agents and Muscle Relaxant Applications
For Muscle Spasm:
*Washington State Evidence Based Preferred Drug List Agents Clinical Efficacy Summary
All muscle relaxants are effective for muscle spasm except
which was not more effective than
Baclofen, dantrolene, and tizanidine
were as effective as diazepam for spasticity.
Diazepam was not studied in this group as it is used primarily for symptoms of anxiety.
has the largest body of evidence supporting its effectiveness.
is a controlled substance in Oregon because of its potential for addiction.
is associated with rare but fatal liver toxicity.
Because of the potential for adverse effects, use of tizanidine
requires that the patient’s liver function be
Evidence-Based Drug Reviews are available at http://www.oregonrx.org
COUNCIL DECISION on the conclusion of the Agreement between the European Union and the Russian Federation on drug precursors EXPLANATORY MEMORANDUM 1. CONTEXT OF THE PROPOSAL On 23 March 2009 the Council authorised the Commission to open negotiations with the Russian Federation for an Agreement on drug precursors. Following the launch of negoti
Ayurvedan mukaan vuodenajat vaikuttavat ihmisen fyysiseen ja psyykkiseen terveyteen. Mitä ankean talven helpottamiseksi voisi tehdä? TEKSTI � JENNIFER�BECKMAN� KUVITUS � ANNA�SALMISALO sesta. Kaamosmasennus on yleistä alavirei- VUODENAIKOJEN�OMINAISUUDET syyttä, joka vaikuttaa ihmisiin erityisesti Doshat lisääntyvät niiden vuodenaikojen ai-vuoden pimeimpinä kuu